AU1541376A - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
AU1541376A
AU1541376A AU15413/76A AU1541376A AU1541376A AU 1541376 A AU1541376 A AU 1541376A AU 15413/76 A AU15413/76 A AU 15413/76A AU 1541376 A AU1541376 A AU 1541376A AU 1541376 A AU1541376 A AU 1541376A
Authority
AU
Australia
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU15413/76A
Other versions
AU505476B2 (en
Inventor
Ekkehard Scheiffele
Guido Weickgenannt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henning Berlin GmbH Chemie- und Pharmawerk
Original Assignee
Henning Berlin GmbH Chemie- und Pharmawerk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henning Berlin GmbH Chemie- und Pharmawerk filed Critical Henning Berlin GmbH Chemie- und Pharmawerk
Publication of AU1541376A publication Critical patent/AU1541376A/en
Application granted granted Critical
Publication of AU505476B2 publication Critical patent/AU505476B2/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
AU15413/76A 1975-12-10 1976-06-29 Pharmaceutical composition Expired AU505476B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEDE255560 1975-12-10
DE19752555609 DE2555609A1 (en) 1975-12-10 1975-12-10 PHARMACEUTICAL PREPARATION FOR THE THERAPY OF HYPERURICAEMIA

Publications (2)

Publication Number Publication Date
AU1541376A true AU1541376A (en) 1978-01-05
AU505476B2 AU505476B2 (en) 1979-11-22

Family

ID=5964014

Family Applications (1)

Application Number Title Priority Date Filing Date
AU15413/76A Expired AU505476B2 (en) 1975-12-10 1976-06-29 Pharmaceutical composition

Country Status (8)

Country Link
AU (1) AU505476B2 (en)
BE (1) BE842389A (en)
CA (1) CA1048933A (en)
DE (1) DE2555609A1 (en)
FR (1) FR2334362A1 (en)
GB (1) GB1493237A (en)
NL (1) NL7605531A (en)
ZA (1) ZA763081B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005046724A1 (en) * 2003-11-14 2005-05-26 Human Cell Systems, Inc. Remedy/preventive for vascular disorders and hypertension and method of screening the same
WO2005082840A1 (en) 2004-03-01 2005-09-09 Japan Science And Technology Agency Process for the allylation of n-acylhydrazones
WO2006012438A2 (en) * 2004-07-21 2006-02-02 University Of Florida Research Foundation, Inc. Compositions and methods for treatment and prevention of insulin resistance
US10005750B2 (en) * 2010-10-06 2018-06-26 J-Pharma Co., Ltd. Developing potent urate transporter inhibitors: compounds designed for their uricosuric action
CN103242272B (en) * 2013-05-22 2016-01-27 合肥医工医药有限公司 A kind of method preparing benzbromarone

Also Published As

Publication number Publication date
FR2334362A1 (en) 1977-07-08
DE2555609A1 (en) 1977-06-30
FR2334362B1 (en) 1979-08-24
NL7605531A (en) 1977-06-14
CA1048933A (en) 1979-02-20
BE842389A (en) 1976-09-16
GB1493237A (en) 1977-11-30
ZA763081B (en) 1977-04-27
AU505476B2 (en) 1979-11-22

Similar Documents

Publication Publication Date Title
AU497066B2 (en) Photocoplymerizable composition
AU515341B2 (en) Pharmaceutical composition
AU514195B2 (en) Dosage form
ZA7671B (en) Pharmaceutical composition
JPS5272829A (en) Pharmaceutical composition
AU497446B2 (en) Composition
AU502644B2 (en) Xanthine-containing pharmaceutical compositions
AU507272B2 (en) Pharmaceutical compositions and compounds
AU504840B2 (en) Medicinal compositions
AU511364B2 (en) Absorption-refrigerant composition
AU508191B2 (en) Pharmaceutical composition
AU505476B2 (en) Pharmaceutical composition
AU505910B2 (en) Neamatocidal composition
AU498557B2 (en) D-homosteroids & pharmaceutical compositions
AU512090B2 (en) Antiinflammatory pharmaceutical compositions
GB1539031A (en) Pharmaceutical compositions
GB1552416A (en) Pharmaceutical compositions
AU498384B2 (en) Anti-timor composition
AU493677B2 (en) Pharmaceutical composition for arteriosclerosis
AU499217B2 (en) Pharmaceutical compositions
IE43955L (en) Pharmaceutical composition
AU488697B2 (en) Pharmaceutical composition
ZA752585B (en) Pharmaceutical composition
AU1287676A (en) New pharmaceutical compositions
AU1172076A (en) Pharmaceutical compositions